As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. We regret to report that long term CardioComm Solutions, Inc. (CVE:EKG) shareholders have had that experience, with the share price dropping 43% in three years, versus a market return of about 16%. The silver lining is that the stock is up 14% in about a week. We don’t think CardioComm Solutions’s revenue of CA$952,028 is enough to establish significant demand. This state of affairs suggests that venture capitalists won’t provide funds on attractive terms. So it seems that the investors focused more on what could be, than paying attention to the current revenues (or lack thereof). It seems likely some shareholders believe that CardioComm Solutions will significantly advance the business plan before too long. As a general rule, if a company doesn’t have much revenue, and it loses money, then it is a high risk investment. There is usually a significant chance that they will need more money for business development, putting them at the mercy of capital markets. So the share pr...